Lymphoid Structures in Lung Inflammation Predict Survival After Therapy
A study of 254 lung cancer patients found that tertiary lymphoid structures in peritumoral inflammation are more mature and prognostically ...
A study of 254 lung cancer patients found that tertiary lymphoid structures in peritumoral inflammation are more mature and prognostically ...
A multicenter real-world study has reported that combining trastuzumab deruxtecan with osimertinib may offer clinical benefit for patients with HER2-overexpressing ...
A single case report shows that pathologic complete response after neoadjuvant chemoimmunotherapy did not restore a safe dissection plane in ...
A new computational framework called JEEPERS detects and corrects methylation errors caused by jagged ends in cell-free DNA, improving cancer ...
A study of 60 NSCLC patients finds that only four texture-based radiomic features remain reproducible across clinical CT, ex vivo ...
A phase II trial reports 11.9-month median overall survival with CIMAvax-EGF plus nivolumab in previously treated advanced NSCLC, with the ...
A droplet microfluidic platform produces uniform HAMA/Matrigel core-shell microspheres of about 450 micrometers for in vitro NSCLC tumor modeling.
A new study reports that the enzyme PLA2G4A promotes non-small cell lung cancer proliferation, survival and metastasis through an SP1–IL-1β–MAPK–HSF1 ...
A new review finds that pretreatment psychological distress is consistently associated with poorer outcomes after immune checkpoint inhibitor therapy, while ...
A new study shows that the stress sensors ATF4 and ATF6 coordinate transcriptional and metabolic responses to glucose deprivation in ...
A systematic review of 43 studies finds that attention-based multimodal deep learning consistently outperforms single-modality approaches across lung cancer diagnostic ...
A retrospective multicenter study linked class III BRAF alterations in metastatic NSCLC to shorter overall survival and distinct co-mutation patterns ...
New results from the global Phase I/II ARROS-1 trial indicate clinically meaningful activity with the investigational drug zidesamtinib in patients ...
A retrospective single-center analysis of 452 Chinese patients with non-small cell lung cancer associated compound and co-occurring EGFR mutations with ...
A 2026 literature review synthesizes clinical, diagnostic, molecular and therapeutic evidence on transformation from non–small cell lung cancer to small ...
In a two-center observational cohort of 120 patients with advanced NSCLC and COPD, higher serum IL-6 measured after six treatment ...
A 1,500-patient next-generation sequencing study from Gazi University reveals EGFR and KRAS as dominant drivers in advanced NSCLC, with distinct ...
A structured AGREE II appraisal of Iran's 2018 national NSCLC guideline found strong clarity of presentation but major weaknesses in ...
A controversial clinical trial has once again thrust homeopathy into the center of a scientific firestorm. In a prospective, randomized, ...
A new systems-level study in 3D lung adenocarcinoma models shows that nutrient availability drives tumour cells into two distinct mitochondrial ...
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.